CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Open-market sale Chief Scientific Officer sold 18,167 shares at $12.12 ($220,246)
- 4 Open-market sale Director sold 18,167 shares at $12.12 ($220,246)
- 4 Open-market sale EVP, Chief Medical Officer sold 1,704 shares at $9.86 ($16,805)
- 4 Open-market sale EVP, Chief Dev. Officer sold 1,991 shares at $9.86 ($19,635)
- 4 Open-market sale EVP, CFO & Treasurer sold 3,947 shares at $9.86 ($38,925)
- 4 Open-market sale Director sold 13,471 shares at $9.86 ($132,851)
- 4 Open-market sale Chief Scientific Officer sold 13,471 shares at $9.86 ($132,851)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Chief Business Officer sold 499 shares at $6.69 ($3,338)
- 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 665 shares (to pay taxes)
- 4 Grant or award SVP Sales & Commercial Ops acquired 7,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Chief Business Officer sold 528 shares at $9.29 ($4,905)
- 4 Grant or award EVP, CFO, Treasurer acquired 5,500 shares (grant or award)
- 4 Exercise or conversion SVP, Chief Business Officer acquired 1,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 31 · 601 filings